CSL
LIVE

Serial Number

87172058

Owner

CSL Limited

Attorney

Scott D. Woldow

Filing Date

Sep 15, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CSL Trademark

Serial Number: 87172058 • Registration: 5522024

CSL is a trademark filed by CSL Limited on September 15, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CSL Limited (92 trademarks)

45 Poplar Road
Parkville, Victoria, 3052 , AU

Entity Type: 11

Trademark Details

Filing Date

September 15, 2016

Registration Date

July 24, 2018

Published for Opposition

March 28, 2017

Goods & Services

Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders, influenza, respiratory disease and disorders; pharmaceutical preparations and substances for the treatment and/or prevention of stroke or heart failure; vaccines; anti-virals; antigens for medical purposes; blood products in this class, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; [ test kits in the class, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes ]

[ Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; cell cultures and media, namely, biological preparations for use in cell cultures other than for medical and veterinary use; cell growth media for growing cells for use in scientific research; cell media for growing cells for use in scientific research, namely, for use in the production of pharmaceuticals, vaccines, monoclonal antibodies and recombinant proteins; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant compliment compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific purposes and for use in industry; chemical preparations, namely, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology in the nature of reagents for use in the preparation of invitro diagnostic kits; chemical preparations, namely, monoclonal antibodies for use in invitro scientific or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells; diagnostic and testing agents for scientific or research use, namely, reagents for use in anti-body screening, blood grouping and the typing and detecting of specific blood cells; diagnostic reagents and preparations except for medical or veterinary use ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 16, 2025 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Jun 16, 2025 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 13, 2025 APRE
TEAS SECTION 8 RECEIVED
Jul 19, 2024 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 24, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 11, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 11, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 11, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 11, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 11, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 11, 2022 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2018 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 24, 2018 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jun 15, 2018 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 15, 2018 AITU
NOTICE OF ALLOWANCE CANCELLED
May 18, 2018 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
May 18, 2018 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 21, 2017 EXRA
SOU EXTENSION 1 GRANTED
Nov 17, 2017 EX1G
SOU EXTENSION 1 FILED
Nov 17, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 17, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 23, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 28, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 22, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2017 CRFA
ASSIGNED TO LIE
Feb 2, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 27, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 27, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 20, 2016 NWOS
NEW APPLICATION ENTERED
Sep 19, 2016 NWAP